Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
DLTx's founder is Timothy Furey.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Loomis Sayles’ Rick Razkowski on the Power of Research and Teamwork in Corporate Bond Strategies
00:10:00
Canadian Gold Corp's Tartan Lake Project: A Deep Dive into Potential High-Grade Gold Deposits
00:10:00
John Canning on Building a Legacy in Private Equity and Community Impact | John Canning, Chairman, Madison Dearborn Partners.
00:10:00
Lithium Supply Needs to Increase Fivefold by 2030
00:10:00
Adventure Box CEO Reflects on Strong Performance in Q4 2019 Report | Christopher Kingdon, CEO, Adventure Box Technology AB.
00:00:00
Capital Ltd is still moving into the mining services industry | PETER STOKES., CHIEF EXECUTIVE OFFICER, CAPITAL LTD
00:10:00
South American Company Successfully Weathers Crisis, CEO Oscar Hasbún Affirms | Oscar Hasbún Martínez - CEO of CSAV
00:10:00
FTE's two new projects |Michael P. Beys ,Interim Chief Executive Officer at FTE Networks Inc
00:10:00
Diamond Miner Optimistic Amid Market Challenges at Cape Town Mining Conference
00:10:00
CTO Chairman at Invest Nest: Unlocking Citigold's Potential | Mr Mark J Lynch – Executive Chairman of Citigold corporation ltd
00:10:00
Transition from Gold to Nickel Exploration at Aston Minerals
00:10:00
#SIEWCast episode featuring Koh Chiap Khiong, CEO of Singapore and Southeast Asia at Sembcorp Industries Ltd, explores key industry insights.